Skip to main content
. Author manuscript; available in PMC: 2010 Apr 5.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):341–351. doi: 10.1002/ajmg.b.30816

Table 4.

Genotype analyses in relation to remission defined by QIDS-C16<5

White non-Hispanic White Hispanic Black
Intron 2
VNTR
Remission N P-
Value(2))
P-
Value(3))
Remission N P-
Value(2))
P-
Value(3))
Remission N P-
Value(2))
P-
Value(3))
9/10 52.9% 17 0.810 1.000 0% 1 1.000 1.000
9/12 70.6% 17 0.088 0.353 100% 1 0.374 1.000
10/10 55.7% 158 0.070 0.282 29.2% 24 0.500 1.000 35.3% 17 1.000 1.000
10/12 49.9% 469 0.619 1.000 38.5% 78 0.880 1.000 37.9% 95 1.000 1.000
12/12 44.1% 381 0.017 0.069 38.5% 91 0.882 1.000 37.9% 116 1.000 1.000
Global P-
Value(1))
        0.041        0.670        1.000
Indel
Promoter
Remission N P-
Value(2))
P-
Value(3))
Remission N P-
Value(2))
P-
Value(3))
Remission N P-
Value(2))
P-
Value(3))
L/L 53.7% 369 0.012 0.024 31.7% 60 0.267 0.533 37.8% 143 0.780 1.000
L/S 45.2% 504 0.058 0.115 39.8% 83 0.656 1.000 41.6% 77 0.567 1.000
S/S 46.2% 195 0.527 1.000 41.5% 53 0.512 1.000 30% 10 0.744 1.000
Global P-
Value(1))
       0.039        0.490        0.787
rs25531 Remission N P-
Value(2))
P-
Value(3))
Remission N P-
Value(2))
P-
Value(3))
Remission N P-
Value(2))
P-
Value(3))
A/A 47.6% 925 0.134 0.267 38.5% 174 0.644 1.000 38.9% 126 0.893 1.000
A/G 54.5% 145 0.129 0.259 35% 20 1.000 1.000 38.3% 94 1.000 1.000
G/G 50% 4 1.000 1.000 0% 2 0.528 1.000 33.3% 12 1.000 1.000
Global P-
Value(1))
       0.287        0.752        0.975
1)

Fisher’s exact test comparing remission rates across all genotypes.

2)

Fisher’s exact test comparing each genotype versus all others in a 2x2 table; not corrected for multiple testing.

3)

Corrected for multiple testing by multiplying Fisher’s P-value by the number of independent genotype tests.